After 'half-baked' data drop, CureVac releases results on mRNA flu, COVID-19 vaccines in older adults

After 'half-baked' data drop, CureVac releases results on mRNA flu, COVID-19 vaccines in older adults

Source: 
Fierce Biotech
snippet: 

Weeks after annoying analysts with a “half-baked” data drop, CureVac is back with more clinical trial results on its GSK-partnered mRNA vaccines against influenza and COVID-19. The update fills a key hole in the earlier release by providing an early look at how the vaccines perform in older adults.